The ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingThe PROACTIVE Celiac Study is a phase 2 clinical trial testing the safety and effects of the investigational medication PRV-015.
Continue ReadingPROACTIVE Celiac Study is a phase 2 clinical trial testing the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.
Continue ReadingAs we head into fall, I am happy to share that our 2023 Virtual Turkey Trot is right around the corner – and our team is gearing up for a terrific event! As our biggest annual fundraiser helping to fund the research, advocacy, and education that moves us toward treatments...